Helicobacter pylori infection in diabetic patients with dyspepsia in Uganda [3]

Digestive and Liver Disease

Volumn 33, Issue 4, 2001, Pages 390-391

  Ravera, M ^a   Bahenda, S ^a   Owor, R ^a   Visona, R ^a  

^a Nsambya Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; TINIDAZOLE;

ANTIBIOTIC THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIGESTIVE TRACT ENDOSCOPY; DRUG EFFICACY; DYSPEPSIA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; PREVALENCE; SIDE EFFECT; UGANDA;

DIABETES COMPLICATIONS; DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; UGANDA;

EID: 0034965861     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Finding the optimum treatment for Helicobacter pylori
2. Incidence of Helicobacter pylori infection in Ghanaian patients with dyspeptic symptoms referred for upper gastrointestinal endoscopy
3. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia
4. Frequency of Helicobacter pylori in gastroscopic biopsy of Ugandan Africans
5. Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: Rarity of the vacA s1 a genotype and natural occurrence of an s2/m 1 allele